96 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
resources and lack of revenues. There is no assurance that the Company will be successful in achieving a return on shareholders’ investment … and others to protect proprietary rights. There can be no assurance that the steps taken by the Company to protect proprietary rights will be adequate
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
to differ materially from those anticipated in such forward-looking statements. No assurance can be given that these expectations will prove … results of a clinical trial do not necessarily predict final results. There can be no assurance that any of our clinical trials will ultimately
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:17pm
) The Company acknowledges and agrees that (A) there can be no assurance that the Manager will be successful in selling the Shares, (B) the Manager will incur … hereof. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
to personnel, financial, and other resources and lack of revenues. There is no assurance that the Company will be successful in achieving a return … partners, acquisition targets and others to protect proprietary rights. There can be no assurance that the steps taken by the Company to protect proprietary
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:13pm
(the “Panel”). The Company would remain listed pending the Panel’s decision. There can be no assurance that if the Company does appeal a subsequent delisting … determination, that such appeal would be successful. Accordingly, there can be no assurance that the Company will be able to regain compliance
424B3
ydz3on1
13 Jun 24
Prospectus supplement
4:12pm
424B3
wt24cy eenc4cqr
13 Jun 24
Prospectus supplement
4:11pm
424B3
lhvye5w31ey
13 Jun 24
Prospectus supplement
4:10pm
424B3
vn0z yjgqbwr5zzbk9jp
13 Jun 24
Prospectus supplement
4:10pm
424B3
1n3ltb
13 Jun 24
Prospectus supplement
4:08pm
6-K
EX-99.2
4haua9nx49xie6do a1
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.4
zasmnuq
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.3
sti7j5kgw9r2vhbpg2f
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-10.1
qkw3hz4cz67l
30 Nov 23
XORTX Announces US ATM Offering
4:04pm
424B5
38r9lhfp6 lvw
29 Nov 23
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.4
qrf5fp0rpc0l3oh ik3c
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm